EDGAR Filing Documents for 0001157523-09-006933

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001157523-09-006933

Filing Date

2009-10-15

Accepted

2009-10-15 17:29:37

Documents

Period of Report

2009-07-31

Document Format Files

Seq	Description	Document	Type	Size
1	LIGHTLAKE THERAPEUTICS, INC. 10-K	a6074458.htm	10-K	641831
2	EXHIBIT 3	a6074458ex3i.htm	EX-3.I	40760
3	EXHIBIT 10-4	a6074458ex10_4.htm	EX-10.4	125086
4	EXHIBIT 10-5	a6074458ex10_5.htm	EX-10.5	102630
5	EXHIBIT 10-6	a6074458ex10_6.htm	EX-10.6	122705
6	EXHIBIT 10-7	a6074458ex10_7.htm	EX-10.7	314170
7	EXHIBIT 31.1	a6074458ex31_1.htm	EX-31.1	14487
8	EXHIBIT 31.2	a6074458ex31_2.htm	EX-31.2	14486
9	EXHIBIT 32.1	a6074458ex32.htm	EX-32.1	8412
10	CPA LOGO	cpa.jpg	GRAPHIC	2354
11	CPA SIGNATURE	cpa_sig.jpg	GRAPHIC	3050
12		fig10-6.jpg	GRAPHIC	74882
13		exhibit3articles.jpg	GRAPHIC	122320
14		exhibit3seal.jpg	GRAPHIC	124760
	Complete submission text file	0001157523-09-006933.txt		1837750

Mailing Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7

Business Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7 416-841-5414

Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)